1. RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells
   Márcia Faria et al, 2017, PLOS ONE CrossRef
2. Molecular Pathology of Thyroid Neoplasms
   Vania Nosé, 2018, Diagnostic Pathology: Endocrine CrossRef
3. Anaplastic Thyroid Carcinoma Treated with Lenvatinib
   JUN-ICHI OHKUBO et al, 2017, The Kurume Medical Journal CrossRef
4. Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
   Veronica Veschi et al, 2023, Nature Communications CrossRef
5. Associations of urinary phthalate metabolites with risk of papillary thyroid cancer
   Hongjian Miao et al, 2020, Chemosphere CrossRef
6. Intracellular signalling mechanisms in thyroid cancer
   Paul Mondragón-Terán et al, 2016, Cirugía y Cirujanos (English Edition) CrossRef
7. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction
   Ya-Chieh Wu et al, 2017, Oncology Letters CrossRef
8. Follicular Carcinoma
   , 2016, Diagnostic Pathology: Head and Neck CrossRef
9. Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
   Hélène Lasolle et al, 2024, Oncogene CrossRef
10. Mecanismos de señalización intracelular en cáncer de tiroides
    Paul Mondragón-Terán et al, 2016, Cirugía y Cirujanos CrossRef
11. Promotion of metastasis of thyroid cancer cells via NRP-2-mediated induction
    Dom-Gene Tu et al, 2016, Oncology Letters CrossRef
12. A model and cooperative co-evolution algorithm for identifying driver pathways based on the integrated data and PPI network
    Kai Zhu et al, 2023, Expert Systems with Applications CrossRef
13. The long and still uncertain journey of BRAF as a prognostic tool in patients with papillary thyroid cancer
    Rafael Selbach Scheffel et al, 2019, Archives of Endocrinology and Metabolism CrossRef
14. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors
    Cecilia Evangelisti et al, 2015, BMC Cancer CrossRef
15. MAPK Inhibition Requires Active RAC1 Signaling to Effectively Improve Iodide Uptake by Thyroid Follicular Cells
    Márcia Faria et al, 2021, Cancers CrossRef
16. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin
    Aparna Lakshmanan et al, 2015, Oncotarget CrossRef
17. Role of thyroid hormones in the neoplastic process: an overview
    Iuri Martin Goemann et al, 2017, Endocrine-Related Cancer CrossRef
18. The Circadian Clock in Cancer Development and Therapy
    Loning Fu et al, 2013, Chronobiology: Biological Timing in Health and Disease CrossRef
19. Extending the Impact of RAC1b Overexpression to Follicular Thyroid Carcinomas
    Márcia Faria et al, 2016, International Journal of Endocrinology CrossRef
20. Proteomic Analysis of Tissue Proteins Related to Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
    Qiyao Zhang et al, 2025, Journal of Proteome Research CrossRef
21. Expression of YY1 in Differentiated Thyroid Cancer
    Jéssica Arribas et al, 2015, Endocrine Pathology CrossRef
22. Evaluation of galectin-3, β-catenin, and nuclear morphometry in different thyroid lesions
    Ahlam A. AbdelMaksoud et al, 2013, Egyptian Journal of Pathology CrossRef
23. Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients
    Vera Tiedje et al, 2016, European Journal of Endocrinology CrossRef
24. Pharmacokinetic evaluation of cabozantinib for the treatment of thyroid cancer
    Spyridon Karras et al, 2013, Expert Opinion on Drug Metabolism & Toxicology CrossRef
25. Immune Response in Thyroid Cancer: Widening the Boundaries
    Laura Sterian Ward, 2014, Scientifica CrossRef
26. Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
    Fabian Pitoia et al, 2024, Reviews in Endocrine and Metabolic Disorders CrossRef
27. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma
    Mírian Romitti et al, 2016, Endocrine-Related Cancer CrossRef
28. The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma
    Rafael Selbach Scheffel et al, 2020, Archives of Endocrinology and Metabolism CrossRef
29. Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Rafael Aguiar Marschner et al, 2023, Cells CrossRef
30. Development and Characterization of a Differentiated Thyroid Cancer Cell Line Resistant to VEGFR-Targeted Kinase Inhibitors
    Crescent R. Isham et al, 2014, The Journal of Clinical Endocrinology & Metabolism CrossRef
31. Mechanisms of RET signaling in cancer: Current and future implications for targeted therapy
    I. Plaza-Menacho et al, 2014, Cellular Signalling CrossRef
32. Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer
    Juan Li et al, 2018, Cancer Cell International CrossRef